4//SEC Filing
Farrow Jeffrey S 4
Accession 0001819790-23-000020
CIK 0001819790other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:05 PM ET
Size
7.7 KB
Accession
0001819790-23-000020
Insider Transaction Report
Form 4
Farrow Jeffrey S
See Remarks
Transactions
- Award
Stock Option (right to buy)
2023-04-24+163,397→ 163,397 totalExercise: $14.62Exp: 2033-04-23→ Common Stock (163,397 underlying) - Award
Restricted Stock Units
2023-04-24+111,525→ 111,525 total→ Common Stock (111,525 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on April 24, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001405253
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:05 PM ET
- Size
- 7.7 KB